Aggarwal Sumit Insider Trades

Insider Trading History

Track insider trading activity for Aggarwal Sumit. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $2.53M 1,672,756 shares
Last Trade
Feb 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.1 260,946 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $5.04M 3,336,144 shares
Last Trade
Feb 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.1 260,946 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $2.13M 1,411,810 shares
Last Trade
Jan 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.5 15,000 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $22.7k 15,000 shares
Last Trade
Jan 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.5 15,000 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $5.43M 3,597,090 shares
Last Trade
Sep 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460 4,597,090 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $0 0 shares
Last Trade
Aug 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.28 42,790 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $599k 396,810 shares
Last Trade
Aug 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.7 196,880 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $302k 199,930 shares
Last Trade
Jan 24, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3 30,000 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $45.3k 30,000 shares
Last Trade
Jan 24, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3 30,000 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $0 0 shares
Last Trade
Oct 16, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$17.2 171,880 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
PRESIDENT AND CEO
Holding Value $257k 169,930 shares
Last Trade
Oct 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.5 165,000 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $104k 68,700 shares
Last Trade
Oct 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.2 171,880 shares
$0.00
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
PRESIDENT AND CEO
Holding Value $90.6k 60,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$229k 60,000 shares
$3.82
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
PRESIDENT AND CEO
Holding Value $104k 68,700 shares
Last Trade
Jan 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$293k 68,700 shares
$4.27
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
10% owner, President And CEO
Holding Value $64.6k 42,790 shares
Last Trade
Feb 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$787k 42,790 shares
$18.40
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
PRESIDENT AND CEO
Holding Value $0 0 shares
Last Trade
Dec 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.06M 279,158 shares
$28.86
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
PRESIDENT AND CEO
Holding Value $298k 197,225 shares
Last Trade
Dec 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.36M 81,933 shares
$28.86
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
PRESIDENT AND CEO
Holding Value $422k 279,158 shares
Last Trade
Dec 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.06M 279,158 shares
$28.86
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
PRESIDENT AND CEO
Holding Value $1.5M 992,409 shares
Last Trade
May 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56M 992,409 shares
$56.40
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
PRESIDENT AND CEO
Holding Value $2.15M 1,423,238 shares
Last Trade
Apr 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$191M 1,423,238 shares
$134.40
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up